The health ministry is readying a rebuttal to the US trade representatives (USTR), following its report that termed that India as one of the leading sources of counterfeit medicines distributed globally, a top government official said. Dismissing the report, Arun Singhal, Additional Secretary in the health ministry told Mint that the government is in the process of drafting a rebuttal as it seeks details on the “vague" report by USTR. In its latest Special 301 report released by the USTR, it claimed that India and China were the leading sources of counterfeit medicines distributed globally. Rubbishing the report, Rajiv Nath, forum Coordinator AiMeD said India needs to refute the report. Government of India needs to similarly work with Indian subject experts for putting forth the Indian industry perspective and trade related issues and address their apprehensions".

Source: Mint May 05, 2019 12:56 UTC